Genprex Chief Manufacturing and Technology Officer to Provide Insight on Manufacturing Gene Therapies
Company to Showcase its Innovate Gene Therapy Programs in Oncology and Diabetes
Exciting Data from University of Pittsburgh Researchers in Non Human Primates that Underpins Genprex’s Gene Therapy Program in Diabetes to be Showcased
Corporate Presentation to Highlight Company's Gene Therapies for Cancer and Diabetes
Corporate and Clinical Presentations to Highlight Company’s Gene Therapies for Cancer and Diabetes
Corporate Presentation to Highlight Company’s Gene Therapies for Cancer and Diabetes
Presentations to highlight the Company’s gene therapies for cancer and diabetes
Investor presentation to highlight the Company’s gene therapies for cancer and diabetes
Genprex's President and Chief Executive Officer, Rodney Varner, will provide an overview of the Company’s gene therapies for cancer and diabetes to investors at the 2022 BIO CEO and Investor Conference and at the 2022 Diamond Equity Research Conference.
HC Wainwright BIOCONNECT 2022 Virtual Conference - January 10-13 Biotech Showcase 2022 - January 10-13 Precision: Lung Cancer World R&D Virtual Summit - January 25-26 CEO Roadshow - January 26
Designed and Secured by Barsec